The GLP-1 formulation is not available in most pharmacies or over-the-counter
Nothing is one-size-fits-all
Semaglutide is a prescription medication that works as a GLP-1 receptor agonist and is FDA-approved to treat obesity, type 2 diabetes, metabolic dysfunction-associated steatohepatitis (MASH), and to reduce the risk of chronic kidney disease and major cardiovascular events
Understanding GLP-1's functions is key to effective weight management strategies
This market-shaping approach is complemented by a bold channel innovation, "LillyDirect," a direct-to-consumer platform that bypasses traditional intermediaries, and a pipeline strategy focused on "Accelerate Novel Modality Development" to build upon its current success
How Cardiology Dealt With the COVID-19 Surge in New York City Case Study Describes One of the First U.S